Aug 13 (Reuters) - Acerus Pharmaceuticals Corporation ASP.TO :
* ACERUS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS
* ACERUS PHARMACEUTICALS CORPORATION QTRLY TOTAL REVENUE $2.1 MILLION VERSUS $1.8 MILLION
* ACERUS PHARMACEUTICALS CORPORATION - PRODUCT REVENUES INCREASED FROM $1.2 MILLION FOR THREE MONTHS ENDED JUNE 30, 2017 TO $2.0 MILLION FOR SAME PERIOD IN 2018
* ACERUS PHARMACEUTICALS CORPORATION QTRLY LOSS $0.03
* ACERUS PHARMACEUTICALS CORPORATION - EXPECTS TO SUBMIT NEW DRUG SUBMISSION FOR AVANAFIL TO HEALTH CANADA IN Q4 OF 2018
* ACERUS PHARMACEUTICALS CORPORATION - CURRENTLY EXPECTS TO SUBMIT A NDS FOR PHARMANEST AB'S SHACT TO HEALTH CANADA IN FIRST HALF OF 2019